missing translation for 'onlineSavingsMsg'
Learn More

PF-06840003, MedChemExpress

Product Code. 16414536
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16414536

Brand: Medchem Express HY101111

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress PF-06840003 (EOS200271) is a highly selective orally bioavailable IDO-1 inhibitor with IC50s of 0.41 μM, 0.59 μM, and 1.5 μM for hIDO-1, dIDO-1, and mIDO-1, respectively.

PF-06840003 (EOS200271) is a highly selective orally bioavailable IDO-1 inhibitor with IC50s of 0.41 μM, 0.59 μM, and 1.5 μM for hIDO-1, dIDO-1, and mIDO-1, respectively.

Specifications

Chemical Name or Material PF-06840003
CAS 198474-05-4
Color Light Yellow
Purity Grade Notes Research
Molecular Formula C12H9FN2O2
Quantity 100 mg
Synonym EOS200271
Solubility Information DMSO : ≥ 100 mg/mL (430.64 mM)
SMILES O=C(C(C1=CNC2=C1C=C(F)C=C2)C3)NC3=O
Molecular Weight (g/mol) 232.21
Formula Weight 232.21
Percent Purity 99.95%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.